Biologics Spine Sports Medicine Top Stories Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft byTim AllenDecember 11, 2025
Biologics Spine From Scalpels to Stem Cells: How Regenerative Medicine Is Changing Spine Surgery byNoah SimmonsDecember 10, 2025
Biologics Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply byJosh SandbergDecember 8, 2025
Biologics Regulatory CERAMENT® V application in the U.S. transferred to the De Novo process byWill SandbergDecember 2, 2025
Biologics Extremities Top Stories Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion byWill SandbergDecember 2, 2025
Biologics Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration byTim AllenNovember 26, 2025
Biologics Recon Regulatory Aesculap Implant Systems Resolves Long-Pending Federal Investigations byJosh SandbergNovember 17, 2025
Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Biologics Regulatory Rapid Nexus Becomes the First Company to Receive FDA Clearance for its Advanced Wound-Healing Device Hemastyl byWill SandbergNovember 13, 2025
Biologics Financial Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business byWill SandbergNovember 13, 2025